Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.26272 | 10 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.24201 | 10 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.26217 | 11 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.19585 | 10 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.23975 | 11 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.27427 | 9 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.27417 | 10 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.23955 | 10 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.22454 | 10 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.25221 | 11 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.23938 | 10 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.23869 | 11 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.25529 | 10 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.24705 | 10 |